Assessment of Cardiovascular Events in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

被引：2
|
作者：
Pagnano, Katia B. B. [1 ]
Assuncao, Paola Morelato [1 ]
Zullli, Roberto [1 ]
Delamain, Marcia T. [1 ]
Duarte, Gislaine Oliveira [1 ]
Lorand-Metze, Irene [2 ]
De Souza, Carmino A., Sr. [1 ]
机构：
[1] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil
[2] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Dept Hematol, Campinas, SP, Brazil
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
10.1182/blood.V126.23.4031.4031
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Cardiovascular Risk and Cardiovascular Events in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors
    Assuncao, Paola Morelato
    Lana, Tamires Prates
    Delamain, Marcia Torresan
    Duarte, Gislaine Oliveira
    Zulli, Roberto
    Lorand-Metze, Irene
    de Souza, Carmino Antonio
    de Paula, Erich Vinicius
    Barbosa Pagnano, Katia Borgia
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (03): : 162 - 166
  • [2] Cardiovascular Events Among Patients with Chronic Myeloid Leukemia (CML) Treated with Tyrosine Kinase Inhibitors (TKIs)
    Sam, Princy Yohannan
    Ahaneku, Hycienth
    Nogueras-Gonzalez, Graciela M.
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Wierda, William G.
    Daver, Naval
    Kadia, Tapan
    Burger, Jan
    Pierce, Sherry
    DiNardo, Courtney D.
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Cortes, Jorge E.
    [J]. BLOOD, 2016, 128 (22)
  • [3] Incidence of cardiovascular events in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors
    Casavecchia, Grazia
    Spinosa, Giuseppina
    De Gennaro, Luisa
    Zicchino, Stefano
    Gravina, Matteo
    Magnesa, Michele
    Di Biase, Matteo
    Brunetti, Natale Daniele
    [J]. ACTA CARDIOLOGICA, 2022, 77 (02) : 130 - 135
  • [4] ASSESSMENT OF PLATELET FUNCTIONS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS
    Sener, Y.
    Akbiyik, F.
    Aydin, S.
    Buyukasik, Y.
    Dikmen, Z. G.
    [J]. HAEMATOLOGICA, 2016, 101 : 743 - 743
  • [5] Tyrosine Kinase Inhibitors-Associated Ischemic Events in Patients Treated for Chronic Myeloid Leukemia
    Quillet, P.
    Bourneau-Martin, D.
    Drablier, G.
    Lagarce, L.
    Laine, P.
    [J]. DRUG SAFETY, 2013, 36 (09) : 821 - 821
  • [6] Costs related to adverse events in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors in Canada
    Newton, N.
    Goetghebeur, M. M.
    Ouagari, K. E.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A62 - A63
  • [7] Collaborative cardiovascular management of patients with chronic myeloid leukemia on tyrosine kinase inhibitors
    Kondapalli, Lavanya
    Worth, Sarah
    Hawi, Riem
    Vachhani, Pankit
    Arora, Garima
    Bhatia, Ravi
    Lenneman, Carrie G.
    [J]. VASCULAR MEDICINE, 2020, 25 (03) : 246 - 254
  • [8] Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system
    Malkan, U. Y.
    Haznedaroglu, I. C.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (12) : 5493 - 5506
  • [9] Vascular complications in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
    Cho, Hee Jeong
    Sohn, Sang-Kyun
    [J]. JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2023, 66 (04): : 224 - 233
  • [10] Molecular studies in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
    Sawyers, CL
    [J]. SEMINARS IN HEMATOLOGY, 2001, 38 (03) : 15 - 21
12345